Seeking Alpha
 

Vringo, Inc. (VRNG)

- NASDAQ
  • Fri, Jan. 23, 1:22 PM
    • A German court has ruled ZTE and Asus didn't infringe the German parts of Vringo's (NASDAQ:VRNG) '136 and '941 European patents. The first patent covers devices (including hotspot-capable hardware) that provide data services between two networks, and the second is related to navigation systems providing traffic info. (8-K)
    • Vringo says it's exploring all possible remedies, including appeal. A German court is also set to rule on the validity of the '136 and '941 patents (the hearing date hasn't yet been set).
    • Vringo has been squaring off against ZTE in many different locales. Last month, a U.K. court ordered ZTE to pay Vringo $938K to cover the latter's legal costs for an infringement suit related to the U.K. part of Vringo's '919 European patent.
    | 8 Comments
  • Tue, Jan. 20, 12:14 PM
    • By a 7-2 margin, the Supreme Court has ruled in favor of Teva Pharmaceuticals in its patent suit against generic drugmakers, thereby reversing a federal appeals court (CAFC) decision that declared a patent in dispute was invalid, and sending the case back for further review.
    • Vringo (NASDAQ:VRNG) appears to have gotten a lift from the ruling. The company is a month removed from stating it will seek a Supreme Court review of the CAFC's adverse ruling against Vringo regarding its infringement suit against Google, after the CAFC denied a petition for an en banc review of its decision. (hat tip: Patent Plays)
    • Shares are still down 82% from where they traded prior to the Google ruling.
    | 37 Comments
  • Dec. 15, 2014, 12:40 PM
    • The federal appeals court that ruled against Vringo (NASDAQ:VRNG) in its infringement suit against Google has denied its petition for en banc review of the ruling.
    • Vringo says it will now seek a Supreme Court review. Lawyer David Boies: "This case presents important questions of patent law and the role of juries in patent cases that require further review. The dissenting opinion is a powerful signal that this case warrants attention."
    • The SC only hears a small fraction of the cases appealed to it. Federal courts have been frequently ruling against IP licensing firms this year, as Unwired Planet can attest.
    | 8 Comments
  • Nov. 28, 2014, 10:07 AM
    • A U.K. patent court has ruled ZTE infringed the U.K. portion of Vringo's (NASDAQ:VRNG) '919 European patent, which covers 3G/4G infrastructure gear. The court also ruled the patent to be valid as amended.
    • A subsequent hearing will be held to address remedies. Vringo has sued ZTE in a number of different markets (I, II, III).
    • Update: ZTE states "the impact of the decision on ZTE’s business operations in the UK is limited as no ZTE products containing technology related to the ‘919’ patent are currently shipped in the country."
    | 7 Comments
  • Oct. 15, 2014, 11:20 AM
    • Not surprisingly (given past statements), Vringo (VRNG +4.9%) has "submitted a petition for rehearing en banc in its case against Google and certain of Google`s customers" to the U.S. federal appeals court that ruled against it in August.
    • Vringo's petition "argues that the majority`s opinion in this case presents important questions of law and is at odds with a series of Supreme Court and Federal Circuit decisions, which do not allow appellate judges to disregard a jury`s detailed findings under these circumstances."
    • Shares have moved higher following the announcement.
    | 9 Comments
  • Sep. 2, 2014, 12:32 PM
    • In a shareholder update, Vringo (NASDAQ:VRNG) says it's "preparing for the next steps" in its legal battle against Google following last month's appeals court ruling.
    • The company also notes it has more than 10 hearings scheduled this year for various IP suits - a list of hearing dates is provided for its disputes with ZTE and Asus - and that it currently has $29M in cash and no debt.
    • Vringo adds it "continues to review assets and strategic opportunities that it believes would add value for our shareholders."
    • Shares still -66% from where they traded prior to the appeals court ruling.
    • Previous: Vringo to seek en banc review of Google ruling
    | 5 Comments
  • Aug. 26, 2014, 12:45 PM
    | 2 Comments
  • Aug. 20, 2014, 12:46 PM
    | Comment!
  • Aug. 20, 2014, 11:14 AM
    • As expected, Vringo (VRNG -8.2%) plans to file a petition for an en banc review of the adverse federal appeals court ruling it received last week for its infringement suit against Google.
    • Federal Circuit rules require Vringo to file a petition by Sep. 15. However, the company has filed an unopposed motion for a 30-day extension.
    • SA author Alexander Maxwell has argued Justice Raymond Chen, who dissented from the appeals court ruling, will likely push for an en banc hearing to be granted.
    | 7 Comments
  • Aug. 19, 2014, 12:49 PM
    | 1 Comment
  • Aug. 18, 2014, 2:10 PM
    • Vringo (VRNG +20.8%) director Joseph Spiegel bought 30K shares on Friday at $0.89, after Vringo cratered in response to an appeals court's ruling on its infringement suit against Google. CFO Anastasia Nyrkovskaya bought 16K shares today at $0.91.
    • Shares still -66% from Thursday's close. SA author Alexander Maxwell argues Vringo's "most likely recourse" following the Google ruling is to request an en banc hearing, which requires all of the judges on the appeals court to rule on the suit. He suspects Justice Raymond Chen, who dissented from the ruling, will "push hard" for an en banc hearing behind closed doors.
    • Should the hearing request be denied, Vringo could appeal to the Supreme Court. But as Maxwell observes, the high court only takes up a small fraction of the thousands of cases appealed to it each year.
    | 6 Comments
  • Aug. 15, 2014, 12:48 PM
    | Comment!
  • Aug. 15, 2014, 12:26 PM
    • Vringo (NASDAQ:VRNG) has cratered after the appeals court handling in its suit against Google ruled Vringo's asserted patent claims are invalid due to obviousness.
    • In a short official statement, Vringo says it's "evaluating its options with respect to the case."
    | 9 Comments
  • Aug. 15, 2014, 11:13 AM
    • The federal appeals court handling Vringo's (VRNG -10.8%) suit against Google has ruled against Vringo, arguing the patent claims it asserts "disclose no new technology, but instead simply recite the use of a generic computer to implement a well-known and widely-practiced technique for organizing information." (the full ruling - .pdf)
    • The appeals court cites a recent Supreme Court ruling that upheld the patentability of software concepts, but barred companies from patenting a mere abstract idea on a computer.
    • Vringo has been halted. Shares plunged shortly before the halt.
    | 10 Comments
  • Jul. 2, 2014, 12:00 PM
    • Vringo (VRNG +4.8%) says it has been mailed a notice by the USPTO stating "it will issue a certificate confirming that all of the claims of U.S. Patent No. 6,314,420 remain valid and unchanged."
    • The '420 patent is one of two being asserted by Vringo in its suit against Google. The USPTO affirmed the validity of the other one (Vringo's '664 patent) last fall.
    • The notice follows a non-final rejection by the USPTO of certain claims within the '420 patent back in January.
    | 4 Comments
  • Jun. 19, 2014, 1:15 PM
    • In a closely-watched case, the Supreme Court has upheld the patentability of software concepts, albeit while setting limits: Companies can't patent a mere abstract idea on a computer, but can patent software ideas that advance or improve upon existing ideas.
    • The ruling comes a month after Sen. Pat Leahy shelved a hotly-contested bill aimed at limiting the power of patent trolls. Many tech giants and startups backed the bill, while IP licensing firms staunchly opposed it.
    • A few licensing firms are trading lower on a moderately down day for tech: VRNG -2.2%. ACTG -1.3%. VHC -2.8%. PRKR -3.8%. SPEX -3.1%.
    • Other related names: RPXC, WILN, DSS, CRDS, MARA.
    | 10 Comments
VRNG vs. ETF Alternatives
Company Description
Vringo, Inc. is engaged in identifying, generating, acquiring, and deriving economic benefits from intellectual property assets. Its intellectual property portfolio consists of over 500 patents and patent applications.